The 5-FU Holter Study
ConditionGastrointestinal Malignancy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Auckland, New Zealand
About this trial
To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy
Eligibility criteria
Qualifiers
Patients with diagnosis of gastrointestinal malignancy
Planned to receive either FOLFOX chemotherapy with any treatment intent
Aged ≥ 18 years at time of signing informed consent form
Disqualifiers
None
Trial design
Treatments tested in this trial
- Holter monitor
Treatment groups
10 Participants
are divided into 1 treatment groupLocations
1Auckland City Hospital1023, Auckland New Zealand
Sponsors and collaborators
University of Auckland, New Zealand
Lead sponsor
Auckland City Hospital
Sponsor institution
Gut Cancer Foundation
Collaborator
Auckland City Hospital
Collaborator
The Heart Group
Collaborator
Source ClinicalTrials.gov